Adaptin Bio (APTN) Assets Average (2023 - 2026)
Adaptin Bio's (APTN) quarterly Assets Average came in at $843784.5 in Q2 2026, down 62.64% year-over-year from $2.3 million in Q2 2025, and up 27.34% quarter-over-quarter from $662638.0 in Q1 2026.
Analysis
Adaptin Bio (APTN) Assets Average (2023 - 2026) Analysis & Trends
Adaptin Bio has disclosed Assets Average across 4 years of filings, most recently posting $843784.5 for Q2 2026.
- In Q2 2026, Assets Average fell 62.64% year-over-year to $843784.5; the TTM figure through Jun 2026 stood at $843784.5 (down 62.64% YoY), while the FY2025 annual figure was $429287.0, up 258.04% from the prior year.
- Assets Average came in at $843784.5 for Q2 2026 at Adaptin Bio, up from $662638.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $2.3 million in Q2 2025 to a low of $322.0 in Q3 2024.
- Average Assets Average over 4 years is $629463.7, with a median of $391253.2 recorded in 2024.
- Year-over-year, Assets Average soared 643295.87% in 2025 and sank 62.64% in 2026.
- Over 4 years, Assets Average stood at $380.0 in 2023, then surged by 31444.34% to $119868.5 in 2024, then soared by 566.83% to $799316.5 in 2025, then gained by 5.56% to $843784.5 in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $843784.5 in Q2 2026, $662638.0 in Q1 2026, and $799316.5 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.45 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.69 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 920.60 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.67 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 881.90 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.43 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 154.46 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 3.18 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 494.25 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | 843,784.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 843,784.50 |
| Mar 31, 2026 | 662,638.00 |
| Dec 31, 2025 | 799,316.50 |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 119,868.50 |
| Sep 30, 2024 | 322.00 |
| Jun 30, 2024 | 351.00 |
| Mar 31, 2024 | 380.00 |
| Dec 31, 2023 | 380.00 |
| Sep 30, 2023 | 440.00 |